1. Home
  2. EDSA vs OP Comparison

EDSA vs OP Comparison

Compare EDSA & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • OP
  • Stock Information
  • Founded
  • EDSA 2015
  • OP 2021
  • Country
  • EDSA Canada
  • OP Greece
  • Employees
  • EDSA N/A
  • OP N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • OP
  • Sector
  • EDSA Health Care
  • OP
  • Exchange
  • EDSA Nasdaq
  • OP Nasdaq
  • Market Cap
  • EDSA 13.8M
  • OP 5.3M
  • IPO Year
  • EDSA N/A
  • OP N/A
  • Fundamental
  • Price
  • EDSA $2.04
  • OP $1.59
  • Analyst Decision
  • EDSA Strong Buy
  • OP
  • Analyst Count
  • EDSA 2
  • OP 0
  • Target Price
  • EDSA $13.00
  • OP N/A
  • AVG Volume (30 Days)
  • EDSA 14.6K
  • OP 9.3M
  • Earning Date
  • EDSA 08-08-2025
  • OP 08-06-2025
  • Dividend Yield
  • EDSA N/A
  • OP N/A
  • EPS Growth
  • EDSA N/A
  • OP N/A
  • EPS
  • EDSA N/A
  • OP N/A
  • Revenue
  • EDSA N/A
  • OP $25,702,000.00
  • Revenue This Year
  • EDSA N/A
  • OP N/A
  • Revenue Next Year
  • EDSA N/A
  • OP N/A
  • P/E Ratio
  • EDSA N/A
  • OP N/A
  • Revenue Growth
  • EDSA N/A
  • OP 35.58
  • 52 Week Low
  • EDSA $1.55
  • OP $0.63
  • 52 Week High
  • EDSA $5.59
  • OP $3.17
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.18
  • OP 51.70
  • Support Level
  • EDSA $1.99
  • OP $1.82
  • Resistance Level
  • EDSA $2.14
  • OP $2.30
  • Average True Range (ATR)
  • EDSA 0.12
  • OP 0.52
  • MACD
  • EDSA 0.02
  • OP -0.04
  • Stochastic Oscillator
  • EDSA 58.62
  • OP 36.55

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: